Beta‑blockers, a widely prescribed class of β‑adrenergic receptor antagonists, are best known for managing cardiovascular conditions such as congestive heart failure and arrhythmias. Recent prescribing trends show a notable uptick in their use for anxiety disorders—especially for performance‑related anxiety.
During a fight‑or‑flight response, adrenaline (epinephrine) and noradrenaline (norepinephrine) surge, binding to β‑adrenergic receptors in the heart and raising heart rate. Beta‑blockers occupy these receptors, diminishing the impact of catecholamines and lowering heart rate and blood pressure. This physiological effect is what makes them attractive for conditions where a racing heart fuels anxiety.
About 31% of Americans will experience an anxiety disorder at some point in their lives. A hallmark symptom is an increased heart rate, which can trigger a feedback loop that intensifies anxiety. By dampening the cardiac response, beta‑blockers may interrupt this cycle.
A systematic review published in 2025 concluded that current evidence does not support beta‑blockers as a primary treatment for generalized anxiety disorders. Many studies were small, dated, and limited in scope. A separate review focused on propranolol—one of the most common beta‑blockers—also found insufficient evidence for broad anxiolytic use.
Despite limited data for long‑term anxiety treatment, beta‑blockers have proven useful for specific, situational anxieties. For example, a study found that 57% of musicians used a beta‑blocker before auditions, and many clinicians prescribe them for test anxiety or public speaking. These drugs provide a rapid, short‑term reduction in physical symptoms without the sedative side effects of benzodiazepines.
Patients should follow a healthcare provider’s guidance and monitor for side effects, such as dizziness or fatigue. Beta‑blockers are not a substitute for psychotherapy or long‑term medication plans but can be a valuable adjunct in targeted scenarios.
In summary, beta‑blockers are best reserved for performance‑related anxiety or acute situations where a racing heart is the primary concern. For generalized or chronic anxiety, evidence favors other therapeutic options.
